Kielstein JT - Search Results

1

[Dosage of renal replacement therapy in acute renal failure].

Kielstein JT. Kielstein JT. Dtsch Med Wochenschr. 2009 Aug;134(34-35):1697-9. doi: 10.1055/s-0029-1234005. Epub 2009 Aug 25. Dtsch Med Wochenschr. 2009. PMID: 19707969 German.

2

Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease.

Widjaja A, Kielstein JT, Horn R, von zur Mühlen A, Kliem V, Brabant G. Widjaja A, et al. Among authors: kielstein jt. Nephrol Dial Transplant. 2000 Jun;15(6):846-50. doi: 10.1093/ndt/15.6.846. Nephrol Dial Transplant. 2000. PMID: 10831639

3

Conversion of Goodpasture's syndrome into membranous glomerulonephritis.

Kielstein JT, Helmchen U, Netzer KO, Weber M, Haller H, Floege J. Kielstein JT, et al. Nephrol Dial Transplant. 2001 Oct;16(10):2082-5. doi: 10.1093/ndt/16.10.2082. Nephrol Dial Transplant. 2001. PMID: 11572902 No abstract available.

4

Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure.

Kielstein JT, Bode-Böger SM, Klein G, Graf S, Haller H, Fliser D. Kielstein JT, et al. Eur J Clin Invest. 2003 May;33(5):370-5. doi: 10.1046/j.1365-2362.2003.01149.x. Eur J Clin Invest. 2003. PMID: 12713449

5

Increased resistin blood levels are not associated with insulin resistance in patients with renal disease.

Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D. Kielstein JT, et al. Am J Kidney Dis. 2003 Jul;42(1):62-6. doi: 10.1016/s0272-6386(03)00409-8. Am J Kidney Dis. 2003. PMID: 12830457

6

Efficiency of high-flux hemodialysis in the treatment of valproic acid intoxication.

Kielstein JT, Woywodt A, Schumann G, Haller H, Fliser D. Kielstein JT, et al. J Toxicol Clin Toxicol. 2003;41(6):873-6. doi: 10.1081/clt-120025355. J Toxicol Clin Toxicol. 2003. PMID: 14677800

7

Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study.

Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, Fliser D. Kielstein JT, et al. Am J Kidney Dis. 2004 Feb;43(2):342-9. doi: 10.1053/j.ajkd.2003.10.021. Am J Kidney Dis. 2004. PMID: 14750100 Clinical Trial.

8

Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition.

Kielstein JT, Simmel S, Bode-Böger SM, Roth HJ, Schmidt-Gayk H, Haller H, Fliser D. Kielstein JT, et al. Kidney Blood Press Res. 2004;27(3):143-7. doi: 10.1159/000078838. Epub 2004 Jun 3. Kidney Blood Press Res. 2004. PMID: 15192321 Clinical Trial.

9

One for all--a multi-use dialysis system for effective treatment of severe thallium intoxication.

Kielstein JT, Linnenweber S, Schoepke T, Fliser D. Kielstein JT, et al. Kidney Blood Press Res. 2004;27(3):197-9. doi: 10.1159/000079811. Epub 2004 Jul 13. Kidney Blood Press Res. 2004. PMID: 15256818

10

A single-pass batch dialysis system: an ideal dialysis method for the patient in intensive care with acute renal failure.

Fliser D, Kielstein JT. Fliser D, et al. Among authors: kielstein jt. Curr Opin Crit Care. 2004 Dec;10(6):483-8. doi: 10.1097/01.ccx.0000145101.58940.dc. Curr Opin Crit Care. 2004. PMID: 15616390 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results